Predicting septic complications of chemotherapy: An analysis of 382 patients treated for small cell lung cancer without dose reduction after major sepsis
- 31 December 1993
- journal article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 29 (1), 81-86
- https://doi.org/10.1016/0959-8049(93)90581-y
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Intensive therapy for small-cell lung cancer using carboplatin alternating with cisplatin, ifosfamide, etoposide, mid-cycle vincristine, and radiotherapy.Journal of Clinical Oncology, 1991
- Dose intensity in cancer chemotherapyBritish Journal of Cancer, 1990
- Ifosfamide, doxorubicin and etoposide in small cell lung cancer patients with poor prognosisEuropean Journal of Cancer and Clinical Oncology, 1990
- A simple outpatient treatment with oral Ifosfamide and oral Etoposide for patients with small cell lung cancer (SCLC)British Journal of Cancer, 1989
- Carboplatin, ifosfamide and etoposide with mid-course vincristine and thoracic radiotherapy for 'limited' stage small cell carcinoma of the bronchusBritish Journal of Cancer, 1989
- Ifosfamide, etoposide, and thoracic irradiation therapy in 163 patients with unresectable small cell lung cancerCancer, 1987
- Pretreatment prognostic factors and scoring system in 407 small‐cell lung cancer patientsInternational Journal of Cancer, 1987
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986
- Evaluation of patients with advanced cancer using the karnofsky performance statusCancer, 1980